Subscribe To
Viracta Therapeutics to Present at the Stifel 2023 Targeted Oncology Days
SAN DIEGO, April 19, 2023 (GLOBE NEWSWIRE) — Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision oncology company focused on the treatment and prevention of virus-associated cancers that impact patients worldwide, today announced that Mark Rothera, its President and Chief Executive Officer, and Lisa Rojkjaer, M.D., its Chief Medical Officer, are scheduled to participate in a […] The post Viracta Therapeutics to Present at the Stifel 2023 Targeted Oncology Days appeared first on ForexTV...
Read More
Posted: Apr 19 2023, 20:30
Author Name: forextv
Views: 102441